
Two experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.

Two experts explain the impact of the drug fenfluramine’s FDA approval in the treatment of Dravet syndrome.

Drs Thiele and Wirrell continue analyzing the benefits of cannabidiol as a therapeutic option for patients with Dravet or Lennox-Gastaut syndromes.

The director of pediatric epilepsy and professor of neurology at Mayo Clinic details the rampant acceleration of telemedicine and how her practice is adjusting to the COVID-19 pandemic.

Published: May 7th 2020 | Updated: